Cardiovascular Systems, Inc.
CSII
CSII was delisted on the 27th of April, 2023.
163 hedge funds and large institutions have $514M invested in Cardiovascular Systems, Inc. in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 64 increasing their positions, 58 reducing their positions, and 16 closing their positions.
31% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 16
10% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 58
3% more funds holding
Funds holding: 158 → 163 (+5)
4% less capital invested
Capital invested by funds: $533M → $514M (-$19.7M)
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $613K
Top Buyers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.06M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$5.34M |
| 3 |
BlackRock
New York
|
+$3.02M |
| 4 |
Goldman Sachs
New York
|
+$2.95M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$2.6M |
Top Sellers
CSII Hedge Fund Activity: Q3 2022 in Review
163 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2022, worth a combined $514M — down 3.7% from $533M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new CSII positions and 16 closed out — a net gain of 5 holders — while 64 added to existing stakes and 58 trimmed.
The largest buyer was Federated Hermes, adding an estimated $8.06M. The largest seller was Brown Capital Management, cutting an estimated $20.5M.
- 163 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q3 2022, up from 158 in Q2 2022.
- Funds reported $514M of Cardiovascular Systems, Inc. stock for Q3 2022, down 3.7% quarter-over-quarter.
- 21 funds opened new Cardiovascular Systems, Inc. positions in Q3 2022 and 16 closed out, a net change of +5 holders.
- The largest Cardiovascular Systems, Inc. buyer in Q3 2022 was Federated Hermes, an estimated $8.06M added.
- The largest Cardiovascular Systems, Inc. seller in Q3 2022 was Brown Capital Management, an estimated $20.5M sold.
Based on aggregated 13F filings for Q3 2022.